Close
Nordic 9Nordic 9

Mid Atlantic Bio Angels (investor - Angel Investor)

United States bioangels.net
See something wrong or missing? Let us know
Offices:New York

Mid Atlantic Bio Angels group (MABA) is an angel investor group focused exclusively on new and emerging life science companies, investing exclusively in therapeutics, devices, diagnostics, and digital health companies, with no geographic limitations.

Average round investment:5.95M USD
Average number per year:1.0
Distribution: 2022 (1)
Portfolio companies: France DeepLife
Mostly invests in: France France (1) Biotech (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Mid Atlantic Bio Angels

Name Criteria
China Zhejiang NHU
83%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
France Aurinvest
83%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
France Groupe IRD
83%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.6
  • Active last 12 months: Yes
France Galia Gestion
80%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
Italy Stefano Bernardi
80%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
Spain CG Health Ventures
80%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Spain Ekarpen
80%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Sweden Hillclimber
80%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United Kingdom Longwall Ventures
80%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Germany Peppermint Venture Partners
80%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Top